WW WW INTERNATIONAL, INC.

Nasdaq corporate.ww.com


$ 32.55 $ -1.89 (-5.5 %)    

Friday, 07-Nov-2025 15:59:58 EST
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 32.48
$ 33.75
$ 32.00 x 100
$ 36.00 x 26
$ 30.90 - $ 34.30
$ 23.01 - $ 46.95
390,891
na
324.38M
nm
$ 0.30
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-11-2025 06-30-2025 10-Q
3 05-06-2025 03-29-2025 10-Q
4 02-28-2025 01-01-1970 10-K
5 11-06-2024 09-28-2024 10-Q
6 08-01-2024 06-29-2024 10-Q
7 05-02-2024 03-30-2024 10-Q
8 02-28-2024 12-30-2023 10-K
9 11-02-2023 09-30-2023 10-Q
10 08-03-2023 07-01-2023 10-Q
11 05-04-2023 04-01-2023 10-Q
12 03-06-2023 12-31-2022 10-K
13 11-03-2022 10-01-2022 10-Q
14 08-04-2022 07-02-2022 10-Q
15 05-05-2022 04-02-2022 10-Q
16 03-01-2022 01-01-2022 10-K
17 11-04-2021 10-02-2021 10-Q
18 08-10-2021 07-03-2021 10-Q
19 05-05-2021 04-03-2021 10-Q
20 02-25-2021 01-02-2021 10-K
21 10-29-2020 09-26-2020 10-Q
22 08-05-2020 06-27-2020 10-Q
23 04-28-2020 03-28-2020 10-Q
24 02-25-2020 12-28-2019 10-K
25 11-06-2019 09-28-2019 10-Q
26 08-07-2019 06-29-2019 10-Q
27 05-03-2019 03-30-2019 10-Q
28 02-26-2019 12-29-2018 10-K
29 11-02-2018 09-29-2018 10-Q
30 08-07-2018 06-30-2018 10-Q
31 05-04-2018 03-31-2018 10-Q
32 02-28-2018 12-30-2017 10-K
33 11-07-2017 09-30-2017 10-Q
34 08-08-2017 07-01-2017 10-Q
35 05-10-2017 04-01-2017 10-Q
36 03-01-2017 12-31-2016 10-K
37 11-08-2016 10-01-2016 10-Q
38 08-09-2016 07-02-2016 10-Q
39 05-10-2016 04-02-2016 10-Q
40 03-02-2016 01-02-2016 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 weightwatchers-glp-1-bet-works-stock-rallies-on-clinical-growth

WW International, Inc. (NASDAQ: WW) reports Q3 2025 results with revenue of $172.1M, a net loss of $58M, and 3M subscribers.

 ww-international-raises-fy2025-sales-guidance-from-685000m-700000m-to-695000m-700000m-vs-737722m-est

WW International (NASDAQ:WW) raises FY2025 sales outlook from $685.000 million-$700.000 million to $695.000 million-$700.000 mi...

 ww-international-q3-adj-eps-044-misses-012-estimate-sales-172091m-miss-177600m-estimate

WW International (NASDAQ:WW) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $0.1...

 watching-ww-international-cedar-grove-capital-management-issues-report-titled-ww-the-value-unlock-is-in-the-credit-agreement

https://www.cedargroveresearch.com/p/ww-the-value-unlock-is-in-the-credit-agreement

 members-can-get-weightwatchers-prescriptions-quicker-thanks-to-amazon-pharmacy-partnership

WW International, Inc. (NASDAQ: WW) partners with Amazon Pharmacy to make weight management drugs more accessible for clinic me...

Core News & Articles

WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed wei...

 ww-international-introduces-weightwatchers-rxflexfund-to-combine-direct-pricing-from-pharmaceutical-manufacturers-with-coverage-for-glp-1

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) ("WeightWatchers" or the "Company&#...

 weightwatchers-next-act-goes-beyond-points-weightwatchers-is-emerging-from-bankruptcy-with-a-plan-to-radically-evolve-new-ceo-tara-comonte-tells-axios--axios

https://www.axios.com/2025/10/16/weightwatchers-glp1-menopause-program

 weightwatchers-names-queen-latifah-spokeswoman-as-they-launch-first-comprehensive-menopause-program

WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed wei...

 morgan-stanley-maintains-equal-weight-on-ww-international-lowers-price-target-to-41

Morgan Stanley analyst Lauren Schenk maintains WW International (NASDAQ:WW) with a Equal-Weight and lowers the price target ...

 ww-international-q2-fy2025-earnings-call-transcript

WW International Q2 FY2025 earnings call transcript

 weightwatchers-sees-revenue-boost-from-semaglutide-prescriptions-despite-subscriber-drop

WW International, Inc. (NASDAQ: WW) stock surged on strong financial results, with Clinical subscription revenues rising and de...

 ww-international-sees-fy2025-sales-685000m-700000m-vs-737722m-est

WW International (NASDAQ:WW) sees FY2025 sales of $685.000 million-$700.000 million vs $737.722 million analyst estimate.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION